Biomet

These days, at least in orthopedics, outcomes demonstrably influence the entire business. Zimmer Biomet is aiming to exert positive influence over the care episode which will cement its position as device supplier of choice.

It’s taken a while, but now the $14 Billion acquisition is final

Italian company acquires Zimmer Uni Knee and Biomet Discovery Elbow System within European Economic Area

With regulatory clearance under its belt, Biomet is now reporting first clinical use of its OsseoTi Porous Technology for total hip arthroplasty

Zimmer is having to do some offloading to satisfy EC concerns about its acquisition of Biomet

Zimmer Holdings, Inc., is offering us an advance preview of its future executive leadership team and organizational structure of what is to be called Zimmer Biomet.

Two of the giants of the orthopedic industry are to become one, with the news that Zimmer and Biomet’s board have agreed to an acquisition. Biomet will cost Zimmer a reported $13.35 Billion, and will still be accretive in its first year.

Orthopaedic giant, Biomet, Inc has released its quarterly financial statements showing a consolidated net sales increase of 7.5% on a constant currency basis, compared with the equivalent period a year ago. The growth comes on the back of a similarly healthy picture a quarter ago.

Biomet, Inc. has reached a settlement amounting to $56 million in Multi-District Litigation (MDL) 2391 relating to its M2A Magnum Hip Implant Products.

Titan Spine has dedicated itself to understanding surface texture and its impact on implantable orthopaedic materials. The company’s lofty ambitions to see its technology driving a paradigm shift have been boosted by recent revenue figures showing rapid growth, coupled with a distribution deal with Ortho giant Biomet in Germany.

Orthopaedic device giant Biomet, Inc., has trumpeted the first U.S. implantation of its Comprehensive® Nano Stemless Shoulder. The procedure was part of an FDA Investigational Device Exemption (IDE) multi-center prospective clinical study.

Biomet Spine is to get a host of range enhancements with the incorporation of newly acquired Lanx, Inc.’s range, including its Timberline® Lateral Approach Fusion System, pictured.

Biomet sees revenue increases entirely due to the DePuy trauma acquisition. Net income increased year on year after exclusion of special items.

Biomet and OrthoSensor will co-promote Biomet’s Vanguard® Complete Knee System and OrthoSensor’s VERASENSE™ in a new deal, of which details have not been disclosed. Coupling the two technologies is expected to result in improved surgical and financial outcomes.

Even without the revenue following the acquisition of DePuy’s trauma business, Biomet’s SET products showed impressive double digit growth. Joints nudged up too, but it’s SET that has underpinned the company’s positive sales momentum.

Biomet has released its financial results for the most recent quarter, showing a net sales increase of 9% compared with a year ago. Income and earnings showed similarly healthy increases, although one-off costs translated into a significantly bigger net loss than in the equivalent period.